compounding semaglutide fda enforcement news today Important Update: Changes to Compounded Availability FDA free to pursue semaglutide

Metabolic Changes: The metabolic benefits (e.g., improved insulin sensitivity) may diminish, potentially increasing the risk of weight-related health issues

Combining treatments may increase the risk of side effects or drug interactions

GLP-1 receptor agonists have been shown to provide superior glycemic control and weight loss relative to the DPP-4 inhibitors

Syringe Units = Volume to Draw (mL) 100 = 0.2 mL 100 = 20 units Semax Dosing Profile (10 mg Vial / 2 mL BAC Water) 300 mcg Dose: Draw 6 units (0.06 mL)

Trying out these berberine patches today #glp1 #fitnessjourney #lemon8challenge #Lemon8 #Lemon8Diary Starting on my 2026 summer body Started these on 8/1

IRB approval status Not applicable